ClinVar Miner

Submissions for variant NM_001276345.2(TNNT2):c.451C>A (p.Arg151=)

dbSNP: rs74315379
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 11
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000036591 SCV000060246 likely benign not specified 2012-01-06 criteria provided, single submitter clinical testing Arg141Arg in exon 10 of TNNT2: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. Arg141Arg in exon 10 of TNNT2 (allele freque ncy = n/a)
GeneDx RCV001719732 SCV000722610 likely benign not provided 2019-10-22 criteria provided, single submitter clinical testing
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario RCV000768723 SCV000900093 likely benign Cardiomyopathy 2022-08-02 criteria provided, single submitter clinical testing
Invitae RCV000874833 SCV001017065 benign Hypertrophic cardiomyopathy 2; Dilated cardiomyopathy 1D; Cardiomyopathy, familial restrictive, 3 2023-12-31 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV000768723 SCV001355069 likely benign Cardiomyopathy 2018-11-18 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV000874833 SCV002810848 benign Hypertrophic cardiomyopathy 2; Dilated cardiomyopathy 1D; Cardiomyopathy, familial restrictive, 3 2021-12-28 criteria provided, single submitter clinical testing
Ambry Genetics RCV003298062 SCV003988657 likely benign Cardiovascular phenotype 2023-04-18 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Genome-Nilou Lab RCV003450706 SCV004181371 likely benign Dilated cardiomyopathy 1D 2023-04-11 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV003450707 SCV004181372 likely benign Cardiomyopathy, familial restrictive, 3 2023-04-11 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV003450705 SCV004181374 likely benign Hypertrophic cardiomyopathy 2 2023-04-11 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV004534772 SCV004755524 likely benign TNNT2-related disorder 2023-10-17 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.